Trials / Completed
CompletedNCT01906164
Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers
A Randomized, Double-blind, Placebo-controlled, First-in-human, 3-Part Study of Orally Administered ALS-008176 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosing, Multiple Ascending Dosing and Food-effect in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Alios Biopharma Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the safety, tolerability, and pharmacokinetics (PK) of orally administered ALS-008176 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ALS-008176 | |
| DRUG | Placebo |
Timeline
- Start date
- 2013-05-31
- Primary completion
- 2013-11-30
- Completion
- 2013-11-30
- First posted
- 2013-07-24
- Last updated
- 2017-10-31
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01906164. Inclusion in this directory is not an endorsement.